Skip to main content
SpringerLink
Log in

Half-Dose Rabeprazole Has an Equal Efficacy to Standard-Dose Rabeprazole on Endoscopic Submucosal Dissection-Induced Ulcer

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Although endoscopic submucosal dissection (ESD)-induced ulcers heal faster and recur less often than non-iatrogenic gastric ulcers, the optimal dosage and duration of proton pump inhibitor treatment for ESD-induced ulcers remain unclear.

Aims

To evaluate the efficacy of half-dose rabeprazole on endoscopic submucosal dissection-induced ulcer compared with standard dose rabeprazole.

Methods

The study was a prospective randomized controlled double-blind trial at a single tertiary hospital. A total of 80 patients who underwent ESD for gastric neoplasia were enrolled. Of these patients, 10 were not followed to completion. Final analysis included the remaining 70 patients. Rabeprazole 20 or 10 mg, depending on randomization, was given orally for 4 weeks after ESD.

Results

Of the 70 patients, 45 (64 %) were men, and the median age was 65.2 ± 9.7 years. The mean ESD-induced ulcer area was 673 mm2. No significant differences in ulcer area reduction ratio (p = 0.49) or ulcer-related symptoms (p = 0.91) were observed between the two groups at 4 weeks after ESD.

Conclusion

For ESD-induced ulcers, treatment with 10 mg of rabeprazole daily produces a similar outcome as 20 mg of rabeprazole with regard to healing efficacy and symptom resolution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Gotoda T, Kondo H, Ono H, et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc. 1999;50:560–563.

    Article  PubMed  CAS  Google Scholar 

  2. Ono H. Endoscopic submucosal dissection for early gastric cancer. Chin J Dig Dis. 2005;6:119–121.

    Article  PubMed  Google Scholar 

  3. Watanabe K, Ogata S, Kawazoe S, et al. Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc. 2006;63:776–782.

    Article  PubMed  Google Scholar 

  4. Mukai S, Cho S, Kotachi T, et al. Analysis of delayed bleeding after endoscopic submucosal dissection for gastric epithelial neoplasms. Gastroenterol Res Pract. 2012;2012:875323.

    PubMed  Google Scholar 

  5. Takizawa K, Oda I, Gotoda T, et al. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection ± an analysis of risk factors. Endoscopy. 2008;40:179–183.

    Article  PubMed  CAS  Google Scholar 

  6. Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer. 2006;9:262–270.

    Article  PubMed  Google Scholar 

  7. Higashiyama M, Oka S, Tanaka S, et al. Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig Endosc. 2011;23:290–295.

    Article  PubMed  Google Scholar 

  8. Muraki Y, Enomoto S, Iguchi M, Fujishiro M, Yahagi N, Ichinose M. Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection. World J Gastrointest Endosc. 2012;4:1–8.

    Article  PubMed  Google Scholar 

  9. Goto O, Fujishiro M, Kodashima S, et al. Short-term healing process of artificial ulcers after gastric endoscopic submucosal dissection. Gut Liver. 2011;5:293–297.

    Article  PubMed  Google Scholar 

  10. Ramakrishnan K, Salinas RC. Peptic ulcer disease. Am Fam Physician. 2007;76:1005–1012.

    PubMed  Google Scholar 

  11. Kakushima N, Yahagi N, Fujishiro M, Kodashima S, Nakamura M, Omata M. The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Dig Endosc. 2004;16:327–331.

    Article  Google Scholar 

  12. Gisbert JP, González L, Calvet X, Roqué M, Gabriel R, Pajares JM. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther. 2001;15:917–926.

    Article  PubMed  CAS  Google Scholar 

  13. Uedo N, Takeuchi Y, Yamada T, et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol. 2007;102:1610–1616.

    Article  PubMed  CAS  Google Scholar 

  14. Akimoto M, Hashimoto H, Shigemoto M, Maeda A, Yamashita K. Effects of antisecretory agents on angiogenesis during healing of gastric ulcers. J Gastroenterol. 2005;40:685–689.

    Article  PubMed  CAS  Google Scholar 

  15. Horai Y, Kimura M, Furuie H, et al. Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes. Aliment Pharmacol Ther. 2001;15:793–803.

    Article  PubMed  CAS  Google Scholar 

  16. Ji S, Kim HS, Kim JW, et al. Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer diseases. J Gastroenterol Hepatol. 2006;21:1381–1387.

    PubMed  CAS  Google Scholar 

  17. Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–225.

    Article  PubMed  Google Scholar 

  18. Svedlund J, Sjödin I, Dotevall G. GSRS-A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–134.

    Article  PubMed  CAS  Google Scholar 

  19. Oh TH, Jung HY, Choi KD, et al. Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks. Dig Dis Sci. 2009;54:1494–1499.

    Article  PubMed  CAS  Google Scholar 

  20. Yamaguchi Y, Katsumi N, Tauchi M, et al. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration. Aliment Pharmacol Ther. 2005;21:111–115.

    Article  PubMed  CAS  Google Scholar 

  21. Ohya TR, Endo H, Kawagoe K, et al. A prospective randomized trial of lafutidine vs. rabeprazole on post-ESD gastric ulcers. World J Gastrointest Endosc. 2010;2:36–40.

    Article  PubMed  Google Scholar 

  22. Ye BD, Cheon JH, Choi KD, et al. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. Aliment Pharmacol Ther. 2006;24:837–843.

    Article  PubMed  CAS  Google Scholar 

  23. Yang Z, Wu Q, Liu Z, Wu K, Fan D. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion. 2011;84:315–320.

    Article  PubMed  CAS  Google Scholar 

  24. Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther. 2000;14:963–978.

    Article  PubMed  CAS  Google Scholar 

  25. Lee SH, Lee CK, Chung IK, et al. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study. Dig Dis Sci. 2012;57:429–434.

    Article  PubMed  CAS  Google Scholar 

  26. Kobayashi M, Takeuchi M, Hashimoto S, et al. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide. Dig Dis Sci. 2012;57:119–126.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-0004734) and JW Pharmaceutical Company.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine and Institute of Lifelong Health, Wonju College of Medicine, Yonsei University, 162, Ilsan-dong, Gangwon-do, Wonju, 220-701, Korea

    Hong Jun Park, Hyun-Soo Kim, Bo Ra Kim, So Yeon Park, Jin Heon Hong, Ki Won Jo & Jae Woo Kim

Authors
  1. Hong Jun Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyun-Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bo Ra Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. So Yeon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jin Heon Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ki Won Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jae Woo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hyun-Soo Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, H.J., Kim, HS., Kim, B.R. et al. Half-Dose Rabeprazole Has an Equal Efficacy to Standard-Dose Rabeprazole on Endoscopic Submucosal Dissection-Induced Ulcer. Dig Dis Sci 58, 1054–1061 (2013). https://doi.org/10.1007/s10620-012-2436-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2436-5

Keywords

Search

Navigation